Single-Cell Analysis of CD19-Specific CAR T Cell Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia

AFFECTION_STATUS - Case control status of the subject for relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL); All subjects are B-ALL patients. (phv00504478.v1.p1)
ANALYTE_TYPE - Analyte Type (phv00504484.v1.p1)
CONSENT - Consent group as determined by DAC (phv00504473.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00504485.v1.p1)
IS_TUMOR - Tumor status (phv00504486.v1.p1)
SAMPLE_ID - Sample ID (phv00504480.v1.p1)
SAMPLE_ID - Sample ID (phv00504476.v1.p1)
SAMPLE_TIME - Time point (week, month, or GMP) a sample was collected (phv00504483.v1.p1)
SAMPLE_TYPE - Type of sample (phv00504482.v1.p1)
SEQUENCE_TYPE - Sequence type (phv00504481.v1.p1)
SUBJECT_ID - Subject ID (phv00504472.v1.p1)
SUBJECT_ID - Subject ID (phv00504477.v1.p1)
SUBJECT_ID - Subject ID (phv00504475.v1.p1)